Clinical Trial Update: Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating omega-3 fatty acid in treating various stages of breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Breast Carcinoma in Situ
• Lobular Breast Carcinoma in Situ
• Stage Ia Breast Cancer
• Stage Ib Breast Cancer
• Stage Iiia Breast Cancer
• Stage Iiib Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• Omega-3 Fatty Acid (omega-3 fatty acids)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ | Phase 2 | Status: COMPLETED | Results posted: 2019-10-30